Sanofi at a glance
Is this your company? Get featured or correct your listing →
Company Snapshot
Sanofi is a Biotech company, based in Paris, France, founded 2004.
Recent changes
- Jul 24, 2026Jul 24, 2026Scribe Therapeutics Prices Upsized IPO With Sanofi Backing Pulse story
Latest Pulse
- Oct 7, 2026WhiteLab Genomics Raises $26M to Design Gene Therapies With AIParis-founded WhiteLab Genomics raised a $26 million Series B led by AVP to expand ALFRED, its AI platform for designing delivery systems for cell and gene therapies.→
- Jul 24, 2026Scribe Therapeutics Prices Upsized IPO With Sanofi BackingGene-editing biotech Scribe Therapeutics priced an upsized IPO at $15 per share, raising $128.7 million with Sanofi as a strategic anchor investor, the first gene-editing IPO in over two years.→
- Jul 10, 2026Doudna-Founded Scribe Therapeutics Files S-1/A for Nasdaq IPOScribe Therapeutics, the CRISPR biotech co-founded by Nobel laureate Jennifer Doudna, amended its S-1 to list on Nasdaq under ticker SCTX, backed by more than $180 million in Sanofi and Eli Lilly partnership payments.→
Coverage Timeline
newest firstAll Coverage
Scribe Therapeutics Prices Upsized IPO With Sanofi Backing
Gene-editing biotech Scribe Therapeutics priced an upsized IPO at $15 per share, raising $128.7 million with Sanofi as a strategic anchor investor, the first gene-editing IPO in over two years.
Doudna-Founded Scribe Therapeutics Files S-1/A for Nasdaq IPO
Doudna-Founded Scribe Therapeutics Files S-1/A for Nasdaq IPO
Scribe Therapeutics, the CRISPR biotech co-founded by Nobel laureate Jennifer Doudna, amended its S-1 to list on Nasdaq under ticker SCTX, backed by more than $180 million in Sanofi and Eli Lilly partnership payments.
Value Add Research
Related Companies
Sanofi FAQ
When was Sanofi founded and where is it based?
Sanofi was founded in 2004 and is headquartered in Paris, France, according to Wikidata.